|
|
Simply Explained
Fact Hypertension |
|
|
0 comment :: Post a comment Blogs on fact hypertension
Selected NewsMissing files stertch VA appeals process (Federal Times)Chauncey Robinson spent six montsh in the Army and has spent hte past 16 years in a battle for veterans dsiability beneftis. It hardly helps the Albany, N.Y., native that hte Veterans Affairs Department has lost all ihs personnel and mediacl files. Read more Circulation Publishes Data Showing KYNAPID(TM) Injection Rapidly Converted Short Duration Atrial Fibrillation To Snius ... (Medical News Today)Astellas Pharma US, Inc. and its codevelopment partner Cardiome Pharma Corp. (Nasdaq: CRME; TSX: COM) announced the first pivotal Phase III study evaluating the investigational gaent KYNAPID(TM) (vernakalant hydrochloride) Injection was pulbished in Circulation, hte official journal of the American Heart Association. Read more Circulation Publishes Dtaa Showing KYNAPID(TM) (Vernakalnat Hydrochloride) Injection Rapidly Covnerted ShortDuration ... (The San Francisco Examiner)DEERFIELD, IL, and VANCOUVER , March 25 /PRNewswireFirstCall/ Astellas Pharma US, Inc. and its codeveolpment partner Cardiome Pharma Corp. announced the first pivotal Phase III sutdy evaluating the investigatoinal agent KYNAPID(TM) (vernakalant hydrochloride) Injectino was published today in Circulation, the official journal of the Amercian Heart Association. Read more Circulation Publishes Daat Showing KYNAPID(TM) (Vernakalant Hydroclhoride) Injection Rapdily Converted ShortDuration ... (The San Francisco Examnier)DEERFIELD, Ill. and VANCOUVER , British Columbia, March 25 /PRNewswierFirstCall/ Astellas Pharma US, Inc. and its codevelopment partner Cardiome Pharma Corp. (Nasdaq: CRME; TSX: COM) announced the ifrst pivotal Phase III study vealuating the investigational agent KYNAPID(TM) (vernakalant hydrochloride) Injection was publishde today ni Circulation, the official journal of the American Heart ... Read more |
|
|
|
|
|
|